FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmaceutical industry and concerns an antidepressant composition containing medicinal substance based on Azaphen. The composition contains the following components, mg/tbl: Azaphen 155.4-158.7; Metocel 80.0-100.0; Microcrystalline cellulose 98.7-102.0; Aerosil 3.7-14.8; Kollidon 25 3.7-11.1; Talc 5.55-11.1; Magnesium stearate 1.85-3.7.
EFFECT: invention provides production of the pharmaceutical composition with prolonged release of the active pharmaceutical component that allows stabilising concentration of the preparation in a human body within 24 hours and thereby reducing frequency rate of the preparation intake within 24 hours to attain the required therapeutic effect.
2 cl, 3 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR PREPARING ERGOT ALKALOIDS PHARMACEUTICAL COMPOSITIONS WITH PROLONGED EFFECT CHARACTERIZING WITH IMPROVED BIOAVAILABILITY AND COMPOSITIONS COMPRISING INDICATED ALKALOIDS | 2000 |
|
RU2256454C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTICONVULSIVE AND PSYCHOTROPIC ACTION | 2007 |
|
RU2342144C1 |
| CLOZAPINE TABLETS WITH DELAYED RELEASE AND METHOD OF OBTAINING THEREOF | 2015 |
|
RU2624229C2 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| CONTROLLED-RELEASE PHARMACEUTICAL PROXODOLOL COMPOSITION | 2007 |
|
RU2356532C2 |
| BIOTIN TABLETS WITH DELAYED RELEASE AND METHOD FOR OBTAINING THEREOF | 2016 |
|
RU2638803C2 |
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
| DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES | 2012 |
|
RU2497504C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIARRHYTHMIC ACTIVITY OF VARIOUS ETIOLOGIES | 2021 |
|
RU2783944C1 |
